Yantai Zhenghai Bio-Tech Co Ltd (300653) - Total Assets
Based on the latest financial reports, Yantai Zhenghai Bio-Tech Co Ltd (300653) holds total assets worth CN¥964.85 Million CNY (≈ $141.19 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Yantai Zhenghai Bio-Tech Co Ltd's book value for net asset value and shareholders' equity analysis.
Yantai Zhenghai Bio-Tech Co Ltd - Total Assets Trend (2012–2024)
This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd's total assets have evolved over time, based on quarterly financial data.
Yantai Zhenghai Bio-Tech Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Yantai Zhenghai Bio-Tech Co Ltd's total assets of CN¥964.85 Million consist of 72.7% current assets and 27.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 11.9% |
| Accounts Receivable | CN¥51.41 Million | 5.3% |
| Inventory | CN¥35.18 Million | 3.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥32.53 Million | 3.3% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 300653 market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yantai Zhenghai Bio-Tech Co Ltd's current assets represent 72.7% of total assets in 2024, an increase from 63.7% in 2012.
- Cash Position: Cash and equivalents constituted 11.9% of total assets in 2024, down from 33.4% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 6.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 5.3% of total assets.
Yantai Zhenghai Bio-Tech Co Ltd Competitors by Total Assets
Key competitors of Yantai Zhenghai Bio-Tech Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO
|
USA | $185.55 Million |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
USA | $1.08 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
BioArctic AB (publ)
ST:BIOA-B
|
Sweden | Skr2.60 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Yantai Zhenghai Bio-Tech Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.89 | 9.93 | 3.64 |
| Quick Ratio | 8.52 | 9.44 | 3.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥632.08 Million | CN¥637.30 Million | CN¥382.13 Million |
Yantai Zhenghai Bio-Tech Co Ltd - Advanced Valuation Insights
This section examines the relationship between Yantai Zhenghai Bio-Tech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.22 |
| Latest Market Cap to Assets Ratio | 0.49 |
| Asset Growth Rate (YoY) | -7.0% |
| Total Assets | CN¥980.11 Million |
| Market Capitalization | $483.33 Million USD |
Valuation Analysis
Below Book Valuation: The market values Yantai Zhenghai Bio-Tech Co Ltd's assets below their book value (0.49x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Yantai Zhenghai Bio-Tech Co Ltd's assets decreased by 7.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Yantai Zhenghai Bio-Tech Co Ltd (2012–2024)
The table below shows the annual total assets of Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥980.11 Million ≈ $143.42 Million |
-6.99% |
| 2023-12-31 | CN¥1.05 Billion ≈ $154.21 Million |
+6.78% |
| 2022-12-31 | CN¥986.90 Million ≈ $144.42 Million |
+6.24% |
| 2021-12-31 | CN¥928.92 Million ≈ $135.93 Million |
+15.32% |
| 2020-12-31 | CN¥805.54 Million ≈ $117.88 Million |
+11.81% |
| 2019-12-31 | CN¥720.45 Million ≈ $105.42 Million |
+23.37% |
| 2018-12-31 | CN¥583.98 Million ≈ $85.46 Million |
+10.02% |
| 2017-12-31 | CN¥530.82 Million ≈ $77.68 Million |
+104.84% |
| 2016-12-31 | CN¥259.14 Million ≈ $37.92 Million |
+29.34% |
| 2015-12-31 | CN¥200.35 Million ≈ $29.32 Million |
+143.41% |
| 2014-12-31 | CN¥82.31 Million ≈ $12.04 Million |
+5.81% |
| 2013-12-31 | CN¥77.79 Million ≈ $11.38 Million |
-15.24% |
| 2012-12-31 | CN¥91.78 Million ≈ $13.43 Million |
-- |
About Yantai Zhenghai Bio-Tech Co Ltd
Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and sales of bioregenerative medical materials in China. The company offers oral repair membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, phosphoric acid etchant, dental pit and fissure sealant, light-curing composite… Read more